APOB and metabolic dysfunction-associated steatotic liver disease: Further, we found a dose-dependent relationship between BMI, WC, Apo-B, triglyceride, and NAFLD; when they were greater than 22.65 kg/m2, 81.04 cm, 1.09 mmol/L, and 0.69 g/L, respectively, an increased risk of NAFLD was observed.